Evaluation of Noopept therapy in patients with cognitive impairment and cardiovascular disease
V. N. Shishkova, L. A. Kapustina, V. A. Shishkov, V. G. Vinokurov · 2024 · Nervous Diseases. 2024;(4):70–76.
Study data at a glance
- Participants or experimental model
- 60 outpatients: 30 received added Noopept and 30 background care alone; 56-day open observational comparison.
- Reported results
- The Noopept group reached a median MoCA score of 26 [26;27], improving by 2 [1;3] points. Reported Schulte-task times were 45.3 [38.5;50.5] seconds versus 55.0 [47.5;59.8] seconds in controls; anxiety and depression scores also improved.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Open observational comparison, without a described placebo or randomized assignment; background treatment and expectation can affect outcomes.
- Short follow-up and a cardiovascular/diabetes population; no healthy-person enhancement or dementia-prevention benefit established.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Primary-publication abstract and metadata; complete methods not appraised
Source access and review scope
Original article abstract indexed from the CyberLeninka PDF checked. Bracketed values preserved as reported; complete methods and safety tables not independently appraised.
Recorded source-check date: 2026-11-01. This date does not imply a completed systematic review.
Source type: Journal publication
Citation and original source
Original source: V. N. Shishkova, L. A. Kapustina, V. A. Shishkov, V. G. Vinokurov. Evaluation of Noopept therapy in patients with cognitive impairment and cardiovascular disease Nervous Diseases. 2024;(4):70–76. 2024.
Molekul research summary: https://molekul.io/research/noopept-vascular-comparison-2024. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry